AGNELLI, Giancarlo
Professor of Internal Med (University of Perugia, Italy)
Director of the Division of Internal Vascular Emergency Medicine and Stroke Unit (University Hospital, Perugia, Italy)
Giancarlo Agnelli is Professor of Internal Medicine at the University of Perugia and Director of the Division of Internal
Vascular Emergency Medicine and Stroke Unit at the University Hospital in Perugia. Professor Agnelli is the Chairman of
the Postgraduate Programme in Emergency Medicine at the University of Perugia.
Professor Agnelli is the Editor-in-Chief of the European Journal of Internal Medicine.
Professor Agnelli received his medical degree and specialization in Internal Medicine from the University of Perugia. He was then a research and clinical fellow at the Department of Medicine, McMaster University, Hamilton, Ontario, Canada, and at the Academic Medical Center, University of Amsterdam, The Netherlands.
Professor Agnelli's research focuses on the clinical trials on the prevention and treatment of cardiovascular disease, including the development of
new anticoagulant agents. He is also exploring the relationship between cancer and thrombosis.
Professor Agnelli has authored more than 560 publications (www. pubmed.com). He is also a reviewer for a number of journals including the New England
Journal of Medicine, The Lancet, Circulation, Blood, Cardiovascular Research, Journal of Thrombosis and Haemostasis and the Journal of the American College of Cardiology.
BAUERSACHS, Rupert
Director of Angiology
Klinikum Darmstadt GmBH, Darmstadt, Germany
Department of Vascular Medicine
Prof. Rupert Bauersachs was appointed Director of the Dept. of Vascular Medicine, Darmstadt, Germany, in 2003.
He received his MD from the University of Munich, was a Postdoc at the Dept. of Pharmacology, Munich and a Research Fellow of the AHA at USC,
Los Angeles, CA. He completed his residency in Internal Medicine in Munich and the Universities of Mainz and Frankfurt. He is certified for
Internal Medicine, Vascular Medicine, Haemostaseology, Diabetology, Phlebology, and Aviation Medicine.
He became a faculty member of the University of Frankfurt and Head of the Dept. of Vascular Medicine in 1999. Since 2012, he has a Professorship
for Vulnerable Individuals and Populations (VIP-TH) at the Center for Thrombosis and Hemostasis (CTH), University of Mainz. He is council member
for the German Societies of Angiology and Phlebology and is active in various other scientific societies. He has published > 100 original papers,
and his scientific work has received several prizes.
BAX, Jeroen
Professor of Cardiology
Leiden University Medical Center (LUMC), The Netherlands
Department of Cardiology
Prof. Dr. Jeroen J. Bax, FESC (Leiden, Netherlands)
ESC Immediate Past-President (2018 – 2020), Jeroen Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center.
His main interests include clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these
clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations,
as well as serving on the editorial boards of many different journals.
TEN BERG, Jurriën
Director of the Cardiology Training Program and Head of the St Antonius Center for Platelet Function Studies
St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands
Dr. Jur ten Berg is the Director of the Cardiology Training Program and Head of the St Antonius Center for Platelet Function Studies, at the St Antonius Hospital, the Netherlands.
Dr. ten Berg received his medical degree from the University of Utrecht, the Netherlands before taking up a residency in cardiology at St Antonius Hospital.
He did his PhD at the University of Nijmegen on Oral Anticoagulation in Percutanous Coronary Intervention (promotor Prof Verheugt).
He recently read for Master of Science in Health Economics at the London School of Economics, the UK. His areas of expertise are acute coronary syndrome, antithrombotic treatment and interventional cardiology.
He has published around 350 peer-reviewed publications (Pubmed).
He is actively involved in research projects in the fields of antiplatelet therapy, PCI, TAVI, anticoagulation, stent thrombosis, pharmacogenetics,
pre-hospital triage of patients with non-ST-elevation ACS and long-term follow up of aortic valve surgery. He is the PI of several trials amongst them the WOEST, POPular, POPular genetics, POPular TAVI, POPular CABG, POPular age.
BÜLLER, Harry
Emeritus Professor of Vascular Medicine
Academic Medical Center, Amsterdam, The Netherlands
Department of Vascular Medicine
Harry Büller, MD, PhD is a professor of Internal Medicine at the Academic Medical Center in Amsterdam. He is specialized in Vascular Medicine. Dr. Büller earned his MD and PhD At the University of Amsterdam. After graduating, he completed his research fellowship in hemostasis and thrombosis at the Departments of Medicine and Clinical Epidemiology and Biostatistics at McMaster University in Hamilton, Ontario, Canada in 1981 and 1982. In 2008 he was appointed Honorary Professor of the Royal Netherlands Academy of Arts and Sciences. He authored and co-authored more than 740 scientific articles of topics in his field. He supervised 52 PhD students.
COPPENS, Michiel
Internist Vascular Medicine & Haemophilia
University Medical Center Amsterdam
Department of Vascular Medicine Amsterdam Cardiovascular Sciences Amsterdam
Dr. Michiel Coppens is a Vascular Medicine internist and staff member at the Department of Vascular Medicine. A national opinion leader on anticoagulant therapy (DOACs in particular) and anticoagulant reversal. He was invited as a member of the guideline committee for the national guideline on antithrombotic therapy. He is a member of the Netherlands Society of Hemophilia Physicians. His research interests focuses on anticoagulant therapy with an emphasis on direct oral anticoagulants and management of bleeding complications. From 2015 onwards. He has published over 75 peer reviewed journals and is an investigator in several large thrombosis related research projects and clinical studies.
DEITELZWEIG, Steven
Professor of Medicine (Ochsner Clinical School, Louisiana, USA & The University of Queensland School of Medicine, Australia)
System Chairman of Hospital Medicine & Medical Director of Regional Business Development (Ochsner Health System, Louisiana, USA)
Steven B. Deitelzweig, MD, MMM, FACC, SFHM currently serves as the system chairman for hospital medicine and medical director of regional business development at Ochsner Health System in New Orleans, Louisiana, USA.
After obtaining his medical degree from the of New York State University at Stony Brook School of Medicine, he completed an internal medicine residency at Cornell University.
He then completed fellowships in vascular medicine and hepatology at Ochsner. He holds an Executive Masters in Healthcare Administration and completed his Master of Medical Management
at Tulane University. He is a Professor of Medicine of the Ochsner Clinical School with the University of Queensland.
An extensive lecturer, Dr Deitelzweig has presented nationally and internationally on a variety of topics, such as heart failure, deep venous thrombosis, pulmonary embolism, acute coronary syndrome,
atrial fibrillation, and anticoagulation. An accomplished author, he has over 125 abstracts and over 50 peer-reviewed publications. He has been a principal investigator on numerous clinical trials.
He earned the Jaffin Scholarly Activity Award for Excellence in Research, 2007 Ochsner Health System Physician Leader of the Year, and Outstanding Student for the Tulane Master of
Medical Management class of 2008. He serves on the Board of Directors for the Society of Hospital Medicine, Anticoagulation Forum and Accreditation Management Board of the American
College of Cardiology. He is also a House of Delegates representative to the American Medical Association.
HACKE, Werner
Senior Professor of Neurology
Heidelberg University Faculty of Medicine, Germany
Department of Neurology
Prof. Hacke was professor and Chairman of the Department of Neurology at the University of Heidelberg in Germany for 27 years, until September 2014. He was the youngest chair of Neurology ever in Germany. Currently he is the first and only Senior Professor of Medicine at the Ruprecht Karls University in Heidelberg and a member of the Heidelberg Academy of Science.
Prof. Hacke is the Founding President of the European Stroke Organization (ESO), Vice President of the World Federation of Neurology (WFN) and most recently the President of the World Stroke Organization (WSO).
His main scientific and clinical interest is in stroke and critical care neurology. He has pioneered the field of hyper-acute stroke management including hyper-acute Stroke Units, critical care of stroke, i.v. thrombolysis (ECASS 1-4)
and initiated several new management options for live threatening infarctions including decompressive surgery (DESTINY I and II). He was also involved in leading roles in in stroke prevention trials such as SPACE I and II, CAPRIE, CHARISMA, and ROCKET-AF).
Prof. Hacke has published over 500 original articles in peer reviewed journals, and a SCI ‘Highly Cited Researcher’ from 2014 onwards.
HEMELS, Martin
Cardiologist-electrophysiologist
Rijnstate Hospital (Arnhem) and Radboud University Medical Center (Nijmegen), The Netherlands
Department of Cardiology
Dr. M.E.W. Hemels FEHRA FESC, is a cardiologist-electrophysiologist in Rijnstate Hospital (Arnhem) and Radboud University Medical Center (Nijmegen) and actively involved in (inter)national studies on anticoagulation in patients with atrial fibrillation (AF) with a focus on elderly. He is chair of the working group ´Connect AF’ of the Dutch Society of Cardiology, active in the EHRA education committee, and principal investigator of the DutchAF registry and GERAF study. He was involved, as representative of the Dutch Cardiology Society, in the ESC AF Guidelines 2016.
HUISMAN, Menno
Professor of Medicine
Leiden University Medical Center (LUMC), the Netherlands
Department of Medicine, section of Thrombosis and Hemostasis
Prof. Menno F. Huisman, is Professor of Medicine and staff member in the Department of Medicine, section of Thrombosis and Hemostasis at the Leiden University Medical Center. He is a coordinator/primary investigator of several diagnostic and therapeutic studies in arterial venous thromboembolism and chair of the Gloria-AF registry, a world-wide registry of antithrombotic treatment in AF patients. He is a member of the Task Force European Guidelines ESC pulmonary embolism 2014 and 2019. Chair of the National Consensus on Antithrombotic Treatment 2016; member of the ACCP guideline committee on VTE treatment as well as member of the European Society of Cardiology guideline committee on pulmonary embolism 2014 and 2019. He published 400 scientific articles and is a reviewer of numerous high impact journals, such as New England Journal of Medicine and Lancet
DE JAEGERE, Peter
Professor in Interventional Cardiology & Catheter-based Valve Treatment
Erasmus University Rotterdam, The Netherlands
Department of Cardiology
Professor in Interventional Cardiology & Catheter-based Valve Treatment
Department of Cardiology, Erasmus University Rotterdam, The Netherlands
PPT de Jaegere received his MD degree from the University Ghent, Belgium in 1983 and followed training in Cardiology at the Free University Brussels, Belgium and the University Hospital Rotterdam, The Netherlands (1983-1990).
From 1990-1996, he was staff member of the Department of Cardiology, Dijkzigt Hospital, University Rotterdam. He was in charge of the clinical stent program which lead to
his PhD thesis “Clinical and Angiographic Evaluation of Intracoronary Stenting in Humans” (1993) and, the publication of the Benestent Study (stent vs balloon angioplasty,
New England Journal of Medicine 1994). From 1996-2004 he was staff member of the Department Cardiology, University Hospital Utrecht during which he directed the Octopus
Study (off-pump bypass surgery vs. coronary stenting, New England Journal of Medicine 2003).
In 2004 he returned to Rotterdam where he set up the Catheter Based Valve program that lead to his nomination and appointment of Professor in Interventional Cardiology at the Erasmus University Rotterdam in 2012.
JUKEMA, Wouter
Professor of Cardiology
Leiden University Medical Center (LUMC), The Netherlands
Department of Cardiology
J. Wouter Jukema, is professor of Cardiology, past Established Clinical Investigator at the Netherlands Heart Foundation and is Chairman of ‘Leiden Vascular Medicine’ at Leiden University Medical Center (LUMC) and co-chairman of the Netherlands Heart Institute in Utrecht, the Netherlands. He is also founding director of the Durrer Center for Cardiogenetic Research in Amsterdam.
He has published over 800 peer reviewed publications (many in top journals e.g. NEJM, Lancet, Science, Nature, Circulation, JACC and EHJ). His main interest is in athero-thrombosis, including interventional cardiology as well as atherosclerosis research (vascular biology, lipid modification, diabetes, anti-thrombotics/anti-platelets and genetics). His expertise is well recognized both in clinical research as well as basic science, with a focus on transgenic animals models
Prof. Jukema is principal investigator in several large interventional/athero-thrombosis studies, a member of various (inter)national athero-thrombosis boards recipient of numerous major (EU) project grants.
Web of Science data: No of Publications: >800, H-factor: >100; Sum of Times Cited:> 40.000.
LOPES, Renato
Professor of Medicine
Duke University Medical Center, Durham - North Carolina, USA
Department of Medicine of the Division of Cardiology
Renato D. Lopes, MD, MHS, PhD is a Professor of Medicine of the Department of Medicine of the Division of Cardiology at Duke University Medical Center,
in Durham, North Carolina, USA. He completed his clinical training at the Federal University of Sao Paulo, Sao Paulo, Brazil and his Cardiology Fellowship at
the Duke Clinical Research Institute (DCRI), serving as Chief Fellow for the research training program during his senior year. He is currently the Director of
Clinical Events Classification (CEC) and the Co-Director of the Integrated Clinical Events-Safety Surveillance Group at the DCRI.
Dr. Lopes has an interest in novel antithrombotic therapies for the management of patients with atrial fibrillation and acute coronary syndromes as well as in
the discovery of new biomarkers in the field of Cardiology. Dr. Lopes has led several national and international clinical trials and registries.
He has also participated in over 127 clinical events committees (CECs) for many important clinical trials, serving as CEC chair for several of these trials and Principal Investigator for 31 of these trials.
Dr. Lopes has delivered more than 450 international lectures, authored or co-authored over 467 peer-reviewed articles and 30 book sections, as well as 8 books.
MIDDELDORP, Saskia
Professor of Medicine, Thrombosis and Haemostasis
University Medical Center & University of Amsterdam, the Netherlands
Department of Vascular Medicine
University Medical Center, University of Amsterdam. She leads the clinical thrombosis and haemostasis research at the Department of Vascular Medicine. Her present research focuses on several aspects of hereditary and acquired thrombophilia, women’s issues in thrombosis and haemostasis, and the clinical evaluation of new anticoagulants. She leads the investigator-initiated ALIFE2 and Highlow trials.
Currently, Saskia Middeldorp is president of the Netherlands Society on Thrombosis and Haemostasis (NVTH), and chair of the INVENT-VTE network.
She is member of the Venous Thrombosis Guideline Coordination Panel and chair of the Thrombophilia Chapter of the American Society of Hematology (ASH).
Saskia Middeldorp co-authored the Pregnancy chapter of the 9th Edition Antithrombotic Guidelines of the American College of Chest Physicians (ACCP) in 2012 and
the ASH pregnancy guideline in 2017. In December 2016, she held the Ham-Wasserman Lecture and received the accompanying award in recognition of pioneering work in
inherited thrombophilia at the annual American Society of Hematology meeting in San Diego.
Saskia supervisors 10 PhD students, has co-authored over 230 peer-reviewed papers and several book chapters, and reviews manuscripts for international scientific journals.
TIELEMAN, Robert
Assistant Professor
Martini Hospital Groningen & University Medical Center Groningen, the Netherlands
Department of Cardiology
Dr. Robert G Tieleman is a cardiologist, clinical electrophysiologist and lecturer at the University Medical Center Groningen, and head of the cardiology department in one of the largest general hospitals in Groningen, the Martini hospital since 2007. He was elected chair of the Dutch Cardiovascular Alliance. Dr. Tielemans is a principal investigator of several national and international studies on anti-thrombotic treatment in AF; the RACE 3, RACE 4 and RACE 5 studies and the principal Investigator Resonance study. He is leading several population screening studies for AF using the MyDiagnostick protocol, that was invented by him. Screening projects are active in The Netherlands, Belgium, Saudi Arabia, Germany. He has authored over 90 peer-reviewed manuscripts and several book chapters on managing cardiac arrhythmias and AF.
VERHEUGT, Freek
Emeritus Professor of Cardiology, Cardiologist
University Medical Centre of Nijmegen (Heart-Lung Centre) & Onze Lieve Vrouwe Gasthuis (OLVG) Amsterdam (Department of Cardiology), The Netherlands
Professor Freek Verheugt is Emeritus Professor of Cardiology at the Heart-Lung Centre of the University Medical Centre of Nijmegen,
The Netherlands, and was Chairman of the Department of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG) in Amsterdam, The Netherlands.
Prof. Verheugt graduated from the University of Amsterdam in 1974 and wrote a thesis on platelet and granulocyte antigens and antibodies.
He trained in cardiology at the Thoraxcenter of the Erasmus Medical Centre, University in Rotterdam. He has been a Professor at the University of
Colorado Health Sciences Center in Denver, CO, USA, and at the Free University in Amsterdam. He was President of the Netherlands Society of Cardiology
between 1999 and 2001. Prof. Verheugt’s main fields of scientific interest are pharmacological and interventional treatments of acute coronary syndromes and atrial fibrillation.
Prof. Verheugt has published over 780 papers in peer-reviewed international journals including The New England Journal of Medicine, The Lancet, Circulation,
Journal of the American College of Cardiology and European Heart Journal, of which he is an Associate Editorial Board Member. He has over 41,000 citations,
an H-index of 82 and is also an editorial advisor of The Lancet, The New England Journal of Medicine and Circulation.
WANNER, Christoph
Professor of Medicine and Head of the Division of Nephrology
University Hospital Würzburg, Germany
Department of Medicine
Prof. Dr. Christoph Wanner is a Professor of Medicine and Head of the Division of Nephrology in the Department of Medicine at the University Hospital of Würzburg. He has received his education at the Universities of Ferrara (Italy), Berlin, Zürich (Switzerland) and Singapore, his resident training at the University of Freiburg (Germany) and a research education at the NIH (Washington/USA).
He has published more than 700 scientific papers. He has conducted the 4D study, was steering committee member of the SHARP and EMPA-REG OUTCOME trials and is co-chair of the EMPA-KIDNEY study.
He has been the Renal Registry Chairman of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and an
Executive Committee member of the Kidney Disease Improving Global Outcomes (KDIGO). Currently he is the President elect of the ERA-EDTA.
He has received a doctor honoris causa from the Charles University Prague in 2012, the 2016 Award from the ERA-EDTA for Outstanding Clinical Contributions
to Nephrology as well as the Franz-Volhard Medaille, the highest award from the German Society of Nephrology in 2018.